A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey
- 1 January 1997
- journal article
- clinical trial
- Published by Wiley in International Journal of Dermatology
- Vol. 36 (1) , 61-63
- https://doi.org/10.1046/j.1365-4362.1997.00022.x
Abstract
An open-labeled, randomized clinical trial to evaluate the efficacy of paromomycin ointment as compared with ketoconazole was conducted on seventy-two patients of both sexes and different ages with the confirmed diagnosis of cutaneous leishmaniasis (CL). All patients had a complete clinical evaluation for other diseases. Patients were excluded if they were pregnant or nursing or if they had serious concomitant diseases. Patients were divided randomly into two treatment groups: in the first group 40 patients were treated with an ointment containing 15% paromomycin sulfate and 12% methylbenzothonium chloride in white soft paraffin (labeled as p-ointment by El-On1) twice daily for 15 days. Treated lesions were left uncovered. The second group consisted of 32 patients who received ketoconazole 400 mg/day orally for 30 days. This dosage was reduced to 200 mg/day for patients below 12 years of age. In all cases the diagnosis was based on positive smear and/or culture. Direct smears were prepared from the exudate obtained by a small incision made at the edge of the lesion with a sterile surgical blade or lancet and stained using the Giemsa method for leishmania bodies (Fig 1). In smear negative and suspected cases aspirates taken by puncturing the lesions were inoculated onto NNN (Novy, McNeal, Nicolle) medium for culture. The cultures were incubated at 28 degrees C and the development of motile promastigotes was observed. Clinical and parasitological evaluations of the patients were performed at the end of the treatment period and 4 weeks post-treatment. A cure was defined as complete healing and disappearance of the lesion or reversible hypopigmentation at the site of lesion. Incomplete or partial improvement was defined as a reduction in the size of a lesion and the absence of parasites on smear or culture. A treatment failure was defined as the absence of any changes in the lesion and persistence of parasites on smear or culture.Keywords
This publication has 17 references indexed in Scilit:
- LeishmaniasisJournal of the American Academy of Dermatology, 1996
- Topical treatment of New World cutaneous leishmaniasis in Belize: A clinical studyJournal of the American Academy of Dermatology, 1993
- INTRALESIONAL TREATMENT OF CUTANEOUS LEISHMANIASIS WITH SODIUM STIBOGLUCONATE ANTIMONYInternational Journal of Dermatology, 1993
- Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control studyJournal of the American Academy of Dermatology, 1992
- Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in GuatemalaThe Journal of Infectious Diseases, 1992
- Cutaneous leishmaniasis acquired during military service in the Middle EastArchives of Dermatology, 1992
- Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasisThe American Journal of Medicine, 1990
- Chemotherapy for Leishmaniasis: Biochemical Mechanisms, Clinical Efficacy, and Future StrategiesClinical Infectious Diseases, 1988
- Topical Treatment of Cutaneous LeishmaniasisJournal of Investigative Dermatology, 1986
- Effects of ketoconazole on growth and sterol biosynthesis of Leishmania mexicana promastigotes in culture☆Molecular and Biochemical Parasitology, 1984